Pfizer, Moderna COVID boosters authorized for children as young as 5 years old
FatCamera         

The US FDA has authorized the updated COVID-19 booster shots for children as young as five years old.
The decision impacts the bivalent shots from Moderna (NASDAQ:MRNA) and Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX). They provide protection against the original COVID strain and the more dominant Omicron subvariants, BA.4 and BA.5.
The Moderna (MRNA) booster is authorized for children as young as six years old, while the Pfizer (PFE)/BioNTech (BNTX) one is authorized for those as young as five years old.
Read how Pfizer (PFE) and BioNTech (BNTX) are using Marvel Comics toÂ promote COVID vaccinations.